Top

Journal of Autism and Developmental Disorders

Gepubliceerd in:

01-07-2012 | Brief Report

Brief Report: Platelet-Poor Plasma Serotonin in Autism

Auteurs: George M. Anderson, Margaret E. Hertzig, P. A. McBride

Gepubliceerd in: Journal of Autism and Developmental Disorders | Uitgave 7/2012

Abstract

Possible explanations for the well-replicated platelet hyperserotonemia of autism include an alteration in the platelet’s handling of serotonin (5-hydroxyserotonin, 5-HT) or an increased exposure of the platelet to 5-HT. Measurement of platelet-poor plasma (PPP) levels of 5-HT appears to provide the best available index of in vivo exposure of the platelet to 5-HT. Mean (±SD) concentrations of PPP 5-HT observed in the autism (N = 18), hyperserotonemic subgroup (N = 5) and control (N = 24) groups were 0.86 ± 0.53, 0.87 ± 0.43 and 0.86 ± 0.36 nM, respectively. The results suggest that the hyperserotonemia of autism is not due to increased exposure of the platelet to 5-HT and make it more likely that the factor(s) contributing to the hyperserotonemia of autism have to do with the platelet’s handling of 5-HT.

vorige artikel Brief Report: Selective Social Anhedonia in High Functioning Autism

volgende artikel Brief Report: The Effect of Delayed Matching to Sample on Stimulus Over-Selectivity

Anderson, G. M. (2007). Measurement of plasma serotonin in autism. Pediatric Neurology, 36, 138.PubMedCrossRef

Anderson, G. M., Cook, E. H., Jr, & Blakely, R. D. (2009). Serotonin rising. New England Journal of Medicine, 360, 2580.PubMedCrossRef

Anderson, G. M., Feibel, F. C., & Cohen, D. J. (1987a). Determination of serotonin in whole blood, PRP, PPP and plasma ultrafiltrate. Life Sciences, 40, 1063–1070.PubMedCrossRef

Anderson, G. M., Gutknecht, L., Cohen, D. J., Brailly-Tabard, S., Cohen, J. H., Ferrari, P., et al. (2002). Serotonin transporter promoter variants in autism: Functional effects and relationship to platelet hyperserotonemia. Molecular Psychiatry, 7, 831–836.PubMedCrossRef

Anderson, G. M., Minderaa, R. B., Cho, S. C., Volkmar, F. R., & Cohen, D. J. (1989). The issue of hyperserotonemia and platelet serotonin exposure: A preliminary study. Journal of Autism and Developmental Disorders, 19, 349–351.PubMedCrossRef

Anderson, G. M., Stevenson, J. M., & Cohen, D. J. (1987b). Steady-state model for plasma free and platelet serotonin in man. Life Sciences, 41, 1777–1785.PubMedCrossRef

Beck, O., Wallen, N. H., Broijersen, A., Larsson, P. T., & Hjemdahl, P. (1993). On the accurate determination of serotonin in human plasma. Biochemical Biophysical Research Communications, 196, 260–266.CrossRef

Bonnin, A., Goeden, N., Chen, K., Wilson, M. L., King, J., Shih, J. C., et al. (2011). A transient placental source of serotonin for the fetal forebrain. Nature, 472, 347–350.PubMedCrossRef

Brand, T., & Anderson, G. M. (2011). The measurement of platelet-poor plasma serotonin: A systematic review of prior reports and recommendations for improved analysis. Clinical Chemistry, 57, 1376–1386.PubMedCrossRef

Bursztejn, C., Ferrari, P., Dreux, C., Braconnier, A., & Lancrenon, S. (1988). Metabolism of serotonin in autism in children. Encephale, 14, 413–419.PubMed

Buznikov, G. A., Lambert, H. W., & Lauder, J. M. (2001). Serotonin and serotonin-like substances as regulators of early embryogenesis and morphogenesis. Cell Tissue Research, 305, 177–186.PubMedCrossRef

Carneiro, A. M., Cook, E. H., Murphy, D. L., & Blakely, R. D. (2008). Interactions between integrin alphaIIbbeta3 and the serotonin transporter regulate serotonin transport and platelet aggregation in mice and humans. Journal of Clinical Investigation, 118, 1544–1552.PubMedCrossRef

Chugani, D. C., Muzik, O., Behen, M., Rothermel, R., Janisse, J. J., Lee, J., et al. (1999). Developmental changes in brain serotonin synthesis capacity in autistic and nonautistic children. Annals of Neurology, 45, 287–295.PubMedCrossRef

Connors, S. L., Matteson, K. J., Sega, G. A., Lozzio, C. B., Carroll, R. C., & Zimmerman, A. W. (2006). Plasma serotonin in autism. Pediatric Neurology, 35, 182–186.PubMedCrossRef

Cook, E., & Leventhal, B. (1996). The serotonin system in autism. Current Opinion in Pediatrics, 8, 348–354.PubMedCrossRef

Cook, E. H., Jr, Leventhal, B. L., & Freedman, D. X. (1988). Free serotonin in plasma: Autistic children and their first-degree relatives. Biological Psychiatry, 24, 488–491.PubMedCrossRef

Coutinho, A. M., Sousa, I., Martins, M., Correia, C., Morgadinho, T., Bento, C., et al. (2008). Evidence for epistasis between SLC6A4 and ITGB3 in autism etiology and in the determination of platelet serotonin levels. Human Genetics, 121, 243–256.CrossRef

Croonenberghs, J., Delmeire, L., Verkerk, R., Lin, A. H., Meskal, A., Neels, H., et al. (2000). Peripheral markers of serotonergic and noradrenergic function in post-pubertal caucasian males with autistic disorder. Neuropsychopharmacology, 22, 275–283.PubMedCrossRef

Cross, S., Kim, S. J., Weiss, L. A., Delahanty, R. J., Sutcliffe, J. S., Leventhal, B. L., et al. (2008). Molecular genetics of the platelet serotonin system in first-degree relatives of patients with autism. Neuropsychopharmacology, 33, 353–360.PubMedCrossRef

Goldberg, J., Anderson, G. M., Zwaigenbaum, L., Hall, G. B., Nahmias, C., Thompson, A., et al. (2009). Cortical serotonin type-2 receptor density in parents of children with autism spectrum disorders. Journal of Autism and Developmental Disorders, 39, 97–104.PubMedCrossRef

Hanley, H. G., Stahl, S. M., & Freedman, D. X. (1977). Hyperserotonemia and amine metabolites in autistic and retarded children. Archives of General Psychiatry, 34, 521–531.PubMedCrossRef

Hérault, J., Petit, E., Martineau, J., Cherpi, C., Perrot, A., Barthélémy, C., et al. (1996). Serotonin and autism: Biochemical and molecular biology features. Psychiatry Research, 65, 33–43.PubMedCrossRef

Launay, J. M., Ferrari, P., Haimart, M., Bursztejn, C., Tabuteau, F., Braconnier, A., et al. (1988). Serotonin metabolism and other biochemical parameters in infantile autism. A controlled study of 22 autistic children. Neuropsychobiology, 20, 1–11.PubMedCrossRef

Lesurtel, M., Graf, R., Aleil, B., Walther, D. J., Tian, Y., Jochum, W., et al. (2006). Platelet-derived serotonin mediates liver regeneration. Science, 312(5770), 104–107.PubMedCrossRef

Makkonen, I., Riikonen, R., Kokki, H., Airaksinen, M. M., & Kuikka, J. T. (2008). Serotonin and dopamine transporter binding in children with autism determined by SPECT. Developmental Medicine and Child Neurology, 50, 593–597.PubMedCrossRef

Martineau, J., Barthélémy, C., Jouve, J., Muh, J. P., & Lelord, G. (1992). Monoamines (serotonin and catecholamines) and their derivatives in infantile autism: Age-related changes and drug effects. Developmental Medicine and Child Neurology, 34, 593–603.PubMedCrossRef

McBride, P. A., Anderson, G. M., Hertzig, M. E., Snow, M. E., Thompson, S. M., Khait, V. D., et al. (1998). Effects of diagnosis, race and pubertal status on platelet serotonin levels in autism and mental retardation. Journal of the American Academy of Child and Adolescent Psychiatry, 37, 767–779.PubMedCrossRef

McBride, P. A., Anderson, G. M., Hertzig, M. E., Sweeney, J. A., Kream, J., Cohen, D. J., et al. (1989). Serotonergic responsivity in male young adults with autistic disorder. Archives of General Psychiatry, 46, 205–212.CrossRef

Minderaa, R. B., Anderson, G. M., Volkmar, F. R., Akkerhuis, G. W., & Cohen, D. J. (1987). Urinary 5-hydroxyindoleacetic acid and whole blood serotonin and tryptophan in autistic and normal subjects. Biological Psychiatry, 22, 933–940.PubMedCrossRef

Mulder, E. J., Anderson, G. M., Kema, I. P., de Bildt, A., van Lang, N. D., den Boer, J. A., et al. (2004). Platelet serotonin levels in pervasive developmental disorders and mental retardation: Diagnostic group differences, within-group distribution, and behavioral correlates. Journal of the American Academy of Child and Adolescent Psychiatry, 43, 491–499.PubMedCrossRef

Mulder, E. J., Anderson, G. M., Kemperman, R. F., Oosterloo-Duinkerken, A., Minderaa, R. B., & Kema, I. P. (2010). Urinary excretion of 5-hydroxyindoleacetic acid, serotonin and 6-sulphatoxymelatonin in normoserotonemic and hyperserotonemic autistic individuals. Neuropsychobiology, 61, 27–32.PubMedCrossRef

Murphy, D. G., Daly, E., Schmitz, N., Toal, F., Murphy, K., Curran, S., et al. (2006). Cortical serotonin 5-HT2A receptor binding and social communication in adults with Asperger’s syndrome: An in vivo SPECT study. American Journal of Psychiatry, 163, 934–936.PubMedCrossRef

Posey, D. J., Erickson, C. A., & McDougle, C. J. (2008). Developing drugs for core social and communication impairment in autism. Child and Adolescent Psychiatric Clinics of North America, 17, 787–801.PubMedCrossRef

Schain, R. J., & Freedman, D. X. (1961). Studies on 5-hydroxyindole metabolism in autistic and other mentally retarded children. Journal of Pediatrics, 58, 315–320.PubMedCrossRef

Spivak, B., Golubchik, P., Mozes, T., Vered, Y., Nechmad, A., Weizman, A., et al. (2004). Low platelet-poor plasma levels of serotonin in adult autistic patients. Neuropsychobiology, 50, 157–160.PubMedCrossRef

Vered, Y., Golubchik, P., Mozes, T., Strous, R., Nechmad, A., Mester, R., et al. (2003). The platelet-poor plasma 5-HT response to carbohydrate rich meal administration in adult autistic patients compared with normal controls. Human Psychopharmacology, 18, 395–399.PubMedCrossRef

Titel: Brief Report: Platelet-Poor Plasma Serotonin in Autism
Auteurs: George M. Anderson
Margaret E. Hertzig
P. A. McBride
Publicatiedatum: 01-07-2012
Uitgeverij: Springer US
Gepubliceerd in: Journal of Autism and Developmental Disorders / Uitgave 7/2012
Print ISSN: 0162-3257
Elektronisch ISSN: 1573-3432
DOI: https://doi.org/10.1007/s10803-011-1371-1

Bohn Stafleu van Loghum

Deel dit onderdeel of sectie (kopieer de link)

Abstract

Log in om toegang te krijgen

Andere artikelen Uitgave 7/2012

Brief Report: An Exploratory Study of Lexical Skills in Bilingual Children with Autism Spectrum Disorder

The Prevalence of Autism Spectrum Disorders in Toddlers: A Population Study of 2-Year-Old Swedish Children

Brief Report: Selective Social Anhedonia in High Functioning Autism

Differentiating High-Functioning Autism and Social Phobia

Brief Report: The Effect of Delayed Matching to Sample on Stimulus Over-Selectivity

The Use of Skilled Strategies in Social Interactions by Groups High and Low in Self-Reported Social Skill